Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Alzheimer's and Parkinson's disease models.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Alzheimer's and Parkinson's disease models.
- Published In:
- Neuropharmacology, 136(Pt B), 251-259 (2018)
- Authors:
- Hölscher, Christian(6)
- Database ID:
- RPEP-03720
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-03720APA
Hölscher, Christian. (2018). Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Alzheimer's and Parkinson's disease models.. Neuropharmacology, 136(Pt B), 251-259. https://doi.org/10.1016/j.neuropharm.2018.01.040
MLA
Hölscher, Christian. "Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Alzheimer's and Parkinson's disease models.." Neuropharmacology, 2018. https://doi.org/10.1016/j.neuropharm.2018.01.040
RethinkPeptides
RethinkPeptides Research Database. "Novel dual GLP-1/GIP receptor agonists show neuroprotective ..." RPEP-03720. Retrieved from https://rethinkpeptides.com/research/holscher-2018-novel-dual-glp1gip-receptor
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.